Or the chronic wound study comes back with positive results that allow for reimbursement by insurance.
That's another $600m market opened up right there (according to PNV's estimates, I'd argue that's an underestimate).
The study is due to be finished this month. I don't know how quickly things get approved for reimbursement in the states but that market may not be far off.
- Forums
- ASX - By Stock
- PNV
- Ann: FY21 BTM Revenue Results
Ann: FY21 BTM Revenue Results, page-164
-
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.54 |
Change
-0.180(6.62%) |
Mkt cap ! $1.753B |
Open | High | Low | Value | Volume |
$2.62 | $2.65 | $2.53 | $4.356M | 1.685M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 29641 | $2.53 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.55 | 22158 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 5967 | 2.530 |
1 | 5000 | 2.520 |
3 | 15158 | 2.510 |
6 | 9548 | 2.500 |
3 | 13606 | 2.490 |
Price($) | Vol. | No. |
---|---|---|
2.550 | 22158 | 2 |
2.560 | 4070 | 2 |
2.570 | 2158 | 1 |
2.580 | 2158 | 1 |
2.590 | 2158 | 1 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |